Predicting Success in the Biotech and Pharma Sectors Mark Schoenebaum of ISI Group earned two top spots on this year's All-America Research Team. Here he explains how he differentiates the good stocks from the bad. Related Articles Biopharma Funds Deliver Market-Beating Returns as Valuations Snap Back Stephen Taub Norway Tops Japan as World’s Largest Asset Owner James Comtois From Chaos to Clarity: Solving Your Daily Data Challenges Sponsored by InterSystems